Canadian Online Pharmacy

CDER New July 9, 2012

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

July 6, 2012


New and Generic Drug Approvals

July 6, 2012

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Erbitux cetuximab Vial; Intravenous Imclone Supplement

 

July 5, 2012

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Azasite azithromycin Solution/Drops; Ophthalmic Inspire Labeling Revision
Biaxin clarithromycin Tablet; Oral Abbott Labeling Revision
Biaxin clarithromycin For Suspension; Oral Abbott Labeling Revision
Biaxin Xl clarithromycin Tablet, Extended Release; Oral Abbott Labeling Revision
H.P. Acthar Gel corticotropin Injectable; Injection Questcor Pharms Labeling Revision
Prograf tacrolimus Capsule; Oral Astellas Labeling Revision
Prograf tacrolimus Injectable; Injection Astellas Labeling Revision
Strattera atomoxetine hydrochloride Capsule; Oral Lilly Labeling Revision

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery